AC Immune (ACIU) Receivables - Net (2014 - 2026)

AC Immune (ACIU) has reported Receivables - Net for 10 consecutive years, with $28.4 million the latest figure, recorded in Q3 2024.

• In Q3 2024, Receivables - Net changed N/A year-over-year to $28.4 million; the TTM figure through Sep 2024 stood at $28.4 million (changed N/A YoY), while the FY2023 annual figure was $16.7 billion, changed N/A from the prior year.
• Receivables - Net eased to $28.4 million in Q3 2024 per ACIU's latest filing, from $16.7 billion in the prior quarter.
• Across five years, Receivables - Net topped out at $16.7 billion in Q4 2023 and bottomed at $7.5 million in Q4 2021.
• Historically, Receivables - Net has averaged $3.4 billion across 4 years, with a median of $62.0 million in 2020.
• Annual changes were most pronounced in 2020 — Receivables - Net soared 21507.65% — and 2021, when it slumped 88.73%.
• AC Immune's Receivables - Net stood at $66.4 million in 2020, then plunged by 88.73% to $7.5 million in 2021, then jumped by 222868.09% to $16.7 billion in 2023, then slumped by 99.83% to $28.4 million in 2024.
• Business Quant data shows ACIU's Receivables - Net at $28.4 million in Q3 2024, $16.7 billion in Q4 2023, and $7.5 million in Q4 2021.